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using intravenous or subcutaneous routes in
newborn dogs under immunosuppression with
anti-lymphocyte serum. Intravenous injec-
tions of tumour cells resulted in miliary
nodules in the lungs and heart in as little as
3 weeks. Melanoma of the subcutis with
metastases in some cases followed subcuta-
neous innoculation. Regression has been
observed following cessation of ALS treat-
ment. Normal cells have not produced
tumours but melanoma cell cultures have
retained this characteristic of malignancy.
NUCLEAR PROTEIN METABOLISM
DURING ONE-DOSE URETHANE
CARCINOGENESIS. C. F. FARNSWORTH
and M. GRONOW. Department of Cancer
Res'arch, University of Leeds.
Treatment of 7-9 day old B6AF1 mice
with a single carcinogenic dose of urethane,
at 1 2 mg/g body weight resulted in an
immediate decrease in liver DNA synthesis
reaching a maximum at about 8-12 h after
injection, the rate of synthesis returning to
normal after 48 h.
Of the nuclear proteins, the non-histone
protein fraction showed a significant decrease
in specific activity 8 h after injection, and an
increase in specific activity 24 h after injec-
tion. Histone and residual proteins did not
show any significant changes.
The proteins present in the non-histone
protein fraction were analysed by isoelectric
focusing electrophoresis. The gels of treated
and control samples showed similar gel
patterns but with a much denser band
appearing in the treated sample having a pI
of 7 4.
Histone and residual protein fractions
were also analysed by electrophoresis and
showed no difference between treated and
control samples.
SOME IMMUNOLOGICAL PARA-
METERS IN RELATION TO PROG-
NOSIS IN PATIENTS WITH CARCI-
NOMA OF THE BRONCHUS. H. M.
ANTHONY and J. A. KIRK. Department of
Cancer Research, University of Leeds, K. E.
MADSON, M. K. MASON and G. H. TEMPLE-
MAN. Killingbeck Hospital, Leeds.
The strength ofDHS skin test response to
Candida albicans, mumps and Old Tuberculin
have been usedto assess the effector reactivity
of the immune system in patients with newly
diagnosed carcinoma of the bronchus. Signi-
ficant positive correlations were found
between the strength ofskin test response and
length of survival, symptom pattern on
diagnosis and general condition on diagnosis.
Most surviving patients retested at 6 months
showed the same strength of skin test re-
sponse in spite of deterioration of general
condition, indicating that immune com-
petence determines general condition rather
than vice versa (Cancer N. Y., in the press).
Studies of T and B lymphocyte popula-
tions in peripheral blood using resetting
techniques identifying 97% of cells of mono-
nuclear preparations of healthy donors have
shown that survival is significantly poorer
among patients with low T lymphocytes or
increased null cells at the time of diagnosis.
STUDIES RELATED TO THE CAR-
RIER PRINCIPLE IN THE DESIGN OF
CYTOTOXIC DRUGS. M. SZEKERKE.
Research Group for Peptide Chemistry,
Hungarian Academy of Science, Budapest.
With the aim ofrationalizing the design of
peptide-type carriers attached to cytotoxic
drugs, attention was focused on the mecha-
nism of carrier function. The interaction of
model peptides with nucleic acids was
analysed by following the thermal denatura-
tion profiles.
Complex formation with DNA reflects
adequately the differences in the anti-tumour
activity of diastereoisomer ax- and y-glutamyl
melphalan derivatives. The changes of
Tm-values of poly I: C-peptide complexes
are in marked contrast to the behaviour ofthe
complexes of DNA with the same peptides.
No differences were detected in the ultra-
violet absorption spectra (250C) of DNA in
the presence of peptides, while with N-
aminoacyl D-glucosamine derivatives inter-
actions are indicated by spectral shifts.
Both for carrier activity and DNA
interaction there seem to exist precise
structural requirements for peptides.